Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Innovent and Lilly Expand Strategic Partnership in Oncology
Innovent Biologics, Inc. (“Innovent”, HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes […]
Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist
French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]
Osso VR Raises $66 Million to Broaden Access to Surgical Education for Healthcare Professionals
Osso VR, a validated virtual reality (VR) surgical training and assessment platform, today announced that […]
CND Life Sciences Adds Two Accomplished Pathologists to Leadership Team
CND Life Sciences, Inc. (www.cndlifesciences.com), an innovative medical diagnostics company pioneering the detection, visualization, and […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
UnityPoint Health Announces New Chief Nursing Officer
UnityPoint Health® is pleased to announce that Dr. D’Andre Carpenter has been selected as Chief […]
Roche Announces Collaboration With Bristol Myers Squibb to Advance Personalised Healthcare Through Digital Pathology Solutions
Roche (SIX: RO, ROG;OTCQX: RHHBY) today announced that it has entered into a collaboration with Bristol […]
David Dimmock, M.D., Joins Creyon Bio as Chief Medical Officer
Creyon Bio, Inc. (“Creyon Bio”), a drug development company engineering RNA-based medicines and their components […]
Clint Carnell Named CEO of InBrace
InBrace, the orthodontic company behind the novel Smartwire® technology, announced today that Clint Carnell will join as […]
Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more